The price of Teladoc Health, Inc. (TDOC) on October 9, 2026 is 5.78 USD, +4.24% on the day. Over 52 weeks the stock traded between 4.40 USD and 9.89 USD; the price now sits 21% of the way up that range. Over the past year the price changed by -33.81%. Market capitalization is 991.47 million USD, rank 2 among 6 stocks of the same industry with a known capitalization.
Prices delayed by 15 minutes
Next earnings report: 04 November 2026 · Earnings calendar
Teladoc Health, Inc. trades on NYSE under the ticker TDOC. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks TDOC has traded between 4.40 $ and 9.89 $. As of 09 October 2026 the price stood 20.78 % of the way from the 52-week low to the high.
Over one year TDOC shares fell 33.81 %; over six months they rose 5.52 %. Volatility over 90 days is 73.80 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 0.4, below the sector median of 3.9. Price to book is 0.7, below the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 5.50 | 5.55 | 5.42 | 5.54 | 5M |
| 07 October 2026 | 5.76 | 5.76 | 5.53 | 5.56 | 4M |
| 06 October 2026 | 5.82 | 5.85 | 5.69 | 5.77 | 4M |
| 05 October 2026 | 5.50 | 5.81 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Teladoc Health, Inc. (TDOC) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2025-12-31, revenue was 2.5bn $, net income was -200.3m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:155 E 44TH STREET SUITE 1700, NEW YORK, NY, 10017, US
Teladoc Health, Inc. reported revenue of 2.5B $ and a net loss of 171M $ over the last four quarters. Net margin is −6.81 %. Revenue changed by −1.50 % year over year. Earnings per share are −0.97 $. Market capitalisation is 991M $.
TDOC has a return on equity of −12.81 %, above the sector median of −41.68 %. Return on assets is −6.10 %, above the sector median of −32.11 %. Operating margin is −8.12 %, above the sector median of −26.84 %.
| 2M |
| AIRSAirSculpt Technologies, Inc. | 1.64 | −1.21 % | 2M |
| SBCSBC Medical Group Holdings Incorporated | 5.42 | +1.50 % | 1M |
| AUNAAuna SA | 5.12 | +0.39 % | 576,950 |
| MRNAModerna, Inc. | 225.00 | +14.21 % | 3.0B |
| 5.48 |
| 5.79 |
| 4M |
| 02 October 2026 | 5.74 | 5.75 | 5.48 | 5.52 | 5M |
| 01 October 2026 | 5.87 | 5.93 | 5.65 | 5.67 | 3M |
| 30 September 2026 | 5.81 | 5.92 | 5.75 | 5.80 | 3M |
| 29 September 2026 | 5.86 | 5.90 | 5.71 | 5.75 | 4M |
| 28 September 2026 | 6.05 | 6.07 | 5.85 | 5.89 | 4M |
| 25 September 2026 | 6.10 | 6.18 | 5.97 | 6.09 | 3M |
| 24 September 2026 | 6.19 | 6.24 | 6.07 | 6.14 | 3M |
| 23 September 2026 | 6.28 | 6.32 | 6.12 | 6.13 | 3M |
| 22 September 2026 | 6.35 | 6.47 | 6.22 | 6.35 | 3M |
| 21 September 2026 | 6.37 | 6.38 | 6.22 | 6.27 | 3M |
| 18 September 2026 | 6.31 | 6.34 | 6.19 | 6.30 | 5M |
| 17 September 2026 | 6.52 | 6.55 | 6.28 | 6.28 | 3M |
| 16 September 2026 | 6.55 | 6.56 | 6.37 | 6.43 | 3M |
| 15 September 2026 | 6.45 | 6.73 | 6.42 | 6.58 | 4M |
| 14 September 2026 | 6.25 | 6.57 | 6.21 | 6.50 | 3M |
| 11 September 2026 | 6.09 | 6.20 | 6.04 | 6.16 | 3M |